Candida Albicans Antigens IgG

Order this test expecting it to tell you whether you have a Candida problem, and the result will probably confuse you. Many healthy adults already carry these antibodies because Candida albicans often lives quietly on the body. A positive result is closer to normal background than to a diagnosis.

That doesn't make the result useless. It carries weight in a narrower setting: possible deep Candida infection in someone who is already very ill. Knowing what this antibody can and can't tell you keeps a common result from turning into a false trail.

What This Antibody Actually Is

IgG stands for immunoglobulin G. It is the long-lived class of antibody your immune system makes after it has met something before. This test measures IgG against Candida albicans in serum. Serum is the liquid part of blood after cells and clotting proteins are removed. Many labs measure it with a plate-based method called ELISA.

Candida albicans is a common yeast. It can live on skin and in the mouth, gut, and vagina without causing disease. Gut colonization is often found in roughly 40 to 60% of healthy people, and other body sites vary. Because your immune system meets it early and often, making antibodies against it can be expected background.

Why Many Healthy People Test Positive

Detectable anti-Candida IgG is common in healthy people, and levels in healthy, colonized, and infected groups can overlap. Older antibody studies found Candida antibodies in healthy controls as well as colonized patients. A high reading on its own does not separate someone with a dangerous infection from someone whose body has simply met Candida before.

So this isn't a good-number, bad-number marker. It is a record of exposure. IgG builds up after your body meets the yeast and can linger long after, which is why a single value tells you more about history than about what is happening right now. To read it well, you need context: symptoms, other tests, and sometimes a second reading over time.

Where It Can Help

The setting where this antibody can help is invasive candidiasis. That means Candida has entered the bloodstream or a deep body site. This is a serious infection that mostly strikes people who are already very sick: intensive care patients, those recovering from major abdominal surgery, people on chemotherapy, and others with weakened immunity. Candida albicans is the most common single Candida species causing invasive disease, though non-albicans species together now account for roughly half of bloodstream isolates. Deep infection can be fatal even with treatment.

Even here, this antibody alone is weak. In a small 2023 study of proven or probable candidemia, a commercial C. albicans IgG assay caught about 29 of 100 cases and correctly cleared about 90 of 100 controls. A negative result does not rule the infection out, and a positive result is not enough to treat.

Why Pairing Tests Can Help More Than One Alone

Candida can shed mannan into the blood early in infection. Mannan is a sugar from the Candida cell wall. The antibody against mannan often rises later, so the sugar test and the antibody test may be positive at different moments. Testing both can catch more cases than either one alone.

Source: Sendid et al., 1999.

For this test, the gap matters. Sendid's antibody was anti-mannan, not the broad Candida albicans IgG result in this article. Newer data also temper the optimism: a 2026 analysis of critically ill ICU patients found anti-Candida antibody assays added little on their own, and combining biomarkers offered no clear advantage over a single one. The practical lesson still holds: when deep Candida infection is a real concern, antibody results work best beside cultures and fungal blood markers, not alone, and no combination rescues a weak marker.

The Autism and Schizophrenia Signal

Beyond infection, a few small human studies have linked blood anti-Candida IgG to conditions where the result should not be used for diagnosis. One study measured plasma anti-Candida IgG in 52 children with autism spectrum disorder and 28 typically developing children. Positivity was 36.5% versus 14.3%. That was an unadjusted comparison, so it cannot tell you whether Candida contributes to autism.

In adults, a case-control study measured C. albicans IgG in blood from 947 people across two cohorts. Seropositivity was linked to schizophrenia in men after accounting for age, race, housing, and socioeconomic status; the same pattern was not seen in women. These are association studies. They are not reasons to test for, diagnose, or treat a psychiatric condition based on this antibody.

Why One Reading Is Not Enough

Because this antibody reflects exposure and shifts slowly, a single value is hard to interpret. In one systemic candidiasis study, IgG against four recombinant Candida proteins was higher in recovery-phase serum than in early serum. That is a related but different measurement from this broad test. In children treated for deep infection, antibody changes also appeared slowly. A trend can help in a high-risk workup, but it is not a clock for treatment.

If you track it, track it only for a concrete reason: suspected deep infection, recovery from one, or a specific immune question. There are no standardized targets for this marker. Your own prior result is more useful than a universal ideal value.

What to Do With an Unexpected Result

A positive result with no symptoms, in an otherwise healthy person, usually needs nothing more than perspective. It is common background. Do not start antifungal treatment or a restrictive diet on the strength of this number alone.

If you are very unwell, especially with fever, recent surgery, a central line, or a weakened immune system, treat a positive as one clue in a larger workup rather than an answer. Useful next steps can include Candida antigen or beta-D-glucan testing, blood cultures, and an infectious disease specialist when a deep infection is plausible. Cultures also identify the exact species and which antifungal will work. Serology cannot.

When Results Can Be Misleading

• Normal colonization: because Candida lives in many healthy people, a positive result can simply mean your body has met it before.
• Cross-reactivity: Candida species share some targets, so a result may partly reflect a relative like Candida tropicalis or Candida parapsilosis rather than Candida albicans alone.
• A weakened immune system: some people with weakened immunity may make a weak or delayed IgG response, so a low result does not always rule out deep infection; in some transplant and low-white-cell patients, though, antibody assays have still performed reasonably.
• Timing: IgG can lag behind early infection and then persist after infection is controlled.
• Assay design: broad C. albicans IgG, anti-mannan IgG, anti-candidalysin IgG, and anti-Als3 IgG are related measurements, but they are not interchangeable.